ATA Guidelines Tools

Anaplastic Thyroid Cancer

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/555197

Contents of this Issue

Navigation

Page 12 of 13

11 Table 4. Examples of Adjuvant/Radiosensitizing Chemotherapy Regimens in Anaplastic Thyroid Carcinoma Regimen Agents/dosages Frequency Paclitaxel // carboplatin Paclitaxel 50 mg/m 2 // carboplatin AUC a 2 mg/m 2 IV Weekly Docetaxel // doxorubicin Docetaxel 60 mg/m 2 IV // doxorubicin 60 mg/m 2 IV (w/pegfilgrastim) or Every 3–4 weeks Docetaxel 20 mg/m 2 IV // doxorubicin 20 mg/m 2 Weekly Paclitaxel Paclitaxel 30–60 mg/m 2 IV Weekly Cisplatin Cisplatin 25 mg/m 2 IV Weekly Doxorubicin Doxorubicin 60 mg/m 2 IV or Every 3 weeks Doxorubicin 20 mg/m 2 IV Weekly a Carboplatin AUC, carboplatin dosed using the Calvert formula with the Cockro & Gault equation, actual body weight, and using a minimum serum creatinine value of 0.7 mg/dL. Table 5. Examples of Chemotherapy Regimens in Advanced Anaplastic Thyroid Carcinoma Regimen Agents/dosages Frequency Paclitaxel // carboplatin Paclitaxel 60–100 mg/m 2 // carboplatin AUC 2 mg/m 2 IV Weekly Paclitaxel 135–175 mg/m 2 // carboplatin AUC 5–6 mg/m 2 IV Every 3–4 weeks Docetaxel // doxorubicin Docetaxel 60 mg/m 2 IV // doxorubicin 60 mg/m 2 IV (w/ pegfilgrastim) or Every 3–4 weeks Docetaxel 20 mg/m 2 IV // doxorubicin 20 mg/m 2 IV Weekly Paclitaxel Paclitaxel 60–90 mg/m 2 IV Weekly Paclitaxel 135–200 mg/m 2 IV Every 3–4 weeks Doxorubicin Doxorubicin 60–75 mg/m 2 IV or Every 3 weeks Doxorubicin 20 mg/m 2 IV Weekly

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Anaplastic Thyroid Cancer